Quick Answer
TherapeuticsMD, Inc. reported Net Income of -$569.0 thousand for fiscal year 2025.
TherapeuticsMD, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$569.0K | +73.9% |
| 2024 | -$2.18M | +78.8% |
| 2023 | -$10.28M | -109.2% |
| 2022 | $112.00M | +165.0% |
| 2021 | -$172.41M | +6.1% |
| 2020 | -$183.52M | -4.2% |
| 2019 | -$176.15M | -32.8% |
| 2018 | -$132.62M | -72.4% |
| 2017 | -$76.93M | +14.4% |
| 2016 | -$89.88M | -5.6% |
| 2015 | -$85.08M | -56.9% |
| 2014 | -$54.22M | -90.8% |
| 2013 | -$28.42M | +19.1% |
| 2012 | -$35.12M | -172.0% |
| 2011 | -$12.91M | -350.3% |
| 2010 | -$2.87M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $152.0K | +125.0% | -72.4% |
| June 30, 2025 | $551.0K | +150.6% | +184.4% |
| March 31, 2025 | -$653.0K | +11.0% | -7.2% |
| September 30, 2024 | -$609.0K | +82.0% | +44.1% |
| June 30, 2024 | -$1.09M | +54.8% | -48.5% |
| March 31, 2024 | -$734.0K | +79.6% | +78.3% |
| September 30, 2023 | -$3.38M | +88.3% | -39.9% |
| June 30, 2023 | -$2.41M | -102.1% | +33.0% |
- TherapeuticsMD, Inc. showed an increase of +73.9% in Net Income compared to the prior fiscal year.
- Over the 2010–2025 period, TherapeuticsMD, Inc.’s net income has grown by 80.2% (from -$2.87 million to -$569.0 thousand).
- The most recent figure is from TherapeuticsMD, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: